Epigenetic editing gets closer to human trials, targeting aging

Scientists are developing epigenetic editing tools that can switch genes on or off without altering DNA—which means they could theoretically reverse age-related changes or disease states. This tech could be a massive step forward for longevity, moving beyond just diagnostics.